Physician

Zeeshan Haq

According to 2025 Medicare claims, Zeeshan Haq (NPI: 1396278438) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 55416-5538. Haq is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Caravan Collaborative Pathways (ACO ID: A4604), and Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Haq's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 722 traditional Medicare patients, billed 35,315 HCPCS/CPT codes, and received $2,569,475 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 767 prescription claims across 239 beneficiaries totaling $33,661 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). 2019 DME data shows 22 claims. Open Payments data shows 1 records totaling $1,480. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,125 to $33,661. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2022 Medicare payment: $14,367 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $723,901 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,569,475 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202254172$14,367
20234638,714$723,901
202472235,315$2,569,475

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$34K2017 Drug cost: $1,125 (USD; Tot_Drug_Cst)2018 Drug cost: $1,394 (USD; Tot_Drug_Cst)2019 Drug cost: $7,306 (USD; Tot_Drug_Cst)2020 Drug cost: $2,803 (USD; Tot_Drug_Cst)2021 Drug cost: $2,508 (USD; Tot_Drug_Cst)2022 Drug cost: $3,460 (USD; Tot_Drug_Cst)2023 Drug cost: $13,443 (USD; Tot_Drug_Cst)2024 Drug cost: $33,661 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171429$1,125
20181733$1,394
201941117$7,306
20202142$2,803
20213366$2,508
20223472$3,460
202392232$13,443
2024239767$33,661

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$387$7742019 Medicare payment: $774 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R22$774
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1391,188$659
67028Injection of drug into eye3761,350$96
92014Established patient complete exam of visual system188211$91
92012Established patient problem focused exam of visual system338534$65
92134Imaging of retina7052,025$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2429,708$12,732
Ketorolac TromethamineKetorolac Tromethamine1747,690$3,922
Atropine SulfateAtropine Sulfate1136,138$3,740
Brimonidine TartrateBrimonidine Tartrate161,304$1,016
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim1053,597$722

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$1,480Ocular Therapeutix, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Zeeshan Haq?

Tedicare shows public-source Medicare data for Zeeshan Haq (NPI 1396278438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zeeshan Haq have ACO affiliation data?

Zeeshan Haq is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Zeeshan Haq?

Zeeshan Haq is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does Zeeshan Haq have Open Payments data?

Zeeshan Haq has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.